NRX Pharmaceuticals, Inc. (NRXP)
2.35
+0.09
(+3.98%)
USD |
NASDAQ |
Dec 09, 16:00
2.345
0.00 (0.00%)
After-Hours: 07:00
NRX Pharmaceuticals Free Cash Flow: -11.86M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Synergy CHC Corp. | -6.635M |
| Acurx Pharmaceuticals, Inc. | -7.854M |
| IGC Pharma, Inc. | -6.262M |
| CEL-SCI Corp. | -17.36M |
| AIM ImmunoTech, Inc. | -13.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.891M |
| Cash from Investing (Quarterly) | -2.561M |
| Cash from Financing (Quarterly) | 9.726M |
| Free Cash Flow Per Share (Quarterly) | -0.13 |
| Free Cash Flow to Equity (Quarterly) | -3.067M |
| Free Cash Flow to Firm (Quarterly) | -2.891M |
| Free Cash Flow Yield | -29.56% |